CT of the Abdomen and Pelvis
JJ · Effective Oct 1, 2015
14 active Medicare policies list K83.1, and 5 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
5 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of K83.1 |
|---|---|---|
| Cholecystokinin Cholescintigraphy | Aug 9, 2023 | Covered |
| Radiofrequency Tumor Ablation | Oct 6, 2023 | Covered |
| Verteporfin (Visudyne) Photodynamic Therapy | Jun 29, 2023 | Covered |
| Policy | Effective | Status of K83.1 |
|---|---|---|
| Cancer Antigen 19-9 Testing | Oct 1, 2026 | Covered |
| Carcinoembryonic Antigen Testing |
National · Effective Oct 1, 2026
JL · Effective Oct 1, 2025
National · Effective Oct 1, 2025
National · Effective Aug 6, 2026
J5 · Effective Oct 1, 2024
| Oct 1, 2026 |
| Covered |